[ORGANIZATION]
Fenebrutinib
Featured in 1 tracked story · first seen
Situations
FDA priority reviews for new medical therapies
2 clusters · 5 sources · last updated
Latest: Roche's fenebrutinib receives FDA priority review for multiple sclerosis
The U.S. Food and Drug Administration (FDA) has granted priority review to several new investigational therapies for various medical conditions. In late September 2026, the FDA granted priority review to Bayer’s elinzan